


1. Ildamen
2. Myofedrin
3. Oxifedrine
4. Oxiphedrin
5. Oxyfedrine
6. Oxyphedrin
1. 16777-42-7
2. Oxyfedrine Hcl
3. Ildamen
4. Modacor
5. L-oxyfedrine Hydrochloride
6. Oxyfedrine L-form Hydrochloride
7. Oxyfedrine Hydrochloride, Dl-
8. 63cf9xk7da
9. H1cac99b4d
10. 14223-94-0
11. Oxyfedrine L-form Hcl
12. Oxyfedrin
13. Dsstox_cid_28558
14. Dsstox_rid_82830
15. Dsstox_gsid_48632
16. 3-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)propan-1-one;hydrochloride
17. Oxyfedrine Hydrochloride (jan)
18. Oxyfedrine Hydrochloride [jan]
19. Myophedrine
20. D,l-oxyphedrine
21. 1-propanone, 3-[[(1s,2r)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-(3-methoxyphenyl)-, Hydrochloride (1:1)
22. Cas-16777-42-7
23. Dl-oxyfedrine Hydrochloride
24. Fda 1576
25. Ncgc00182060-02
26. Einecs 240-828-1
27. Unii-h1cac99b4d
28. Oxyfedrine Dl-form Hydrochloride
29. D563
30. D 563
31. Propiophenone, 3-((beta-hydroxy-alpha-methylphenethyl)amino)-3'-methoxy-, Hydrochloride, D,l-
32. 1-propanone, 3-(((1s,2r)-2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hydrochloride (1:1)
33. Ildamen (tn)
34. Unii-63cf9xk7da
35. L-3-methoxy-omega-(1-hydroxy-1-phenylisopropylamino)propiophenone Hydrochloride
36. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hcl, L-
37. L-(1-hydroxy-1-phenyl-2-propylamino)-1-(m-methoxyphenyl)-1-propanone Hydrochloride
38. L-3-(beta-hydroxy-alpha-methyl-phenethylamino)-3'-methoxypropiophenone, Hydrochloride
39. Schembl209076
40. Chembl2354521
41. Dtxsid0048632
42. Fda-1576
43. Tox21_112976
44. Akos037653995
45. Tox21_112976_1
46. Ks-1460
47. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hcl, D,l-
48. D,l-3-(beta-hydroxy-alpha-methyl-phenethylamino)-3'-methoxypropiophenone, Hydrochloride
49. Oxyfedrine Hydrochloride [mart.]
50. Oxyfedrine Hydrochloride, (-)-
51. Propiophenone, 3-((beta-hydroxy-alpha-methylphenethyl)amino)-3'-methoxy-, Hydrochloride, (-)-
52. Ncgc00182060-03
53. Oxyfedrine Hydrochloride [who-dd]
54. (r*,s*)-(+-)-3-((2-hydroxy-1-methyl-2-phenethyl)amino)-1-(3-methoxyphenyl)-1-propanone Hydrochloride
55. (r-(r*,s*))-3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-3'-methoxypropiophenone Hydrochloride
56. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenethyl)amino)-1-(3-methoxyphenyl)-, Hcl, (r*,s*)-
57. D-563
58. Oxyfedrine Dl-form Hydrochloride [mi]
59. Oxyfedrine L-form Hydrochloride [mi]
60. D01233
61. A810903
62. 1-(3-methoxyphenyl)-3-[[(1r,2s)-1-oxidanyl-1-phenyl-propan-2-yl]amino]propan-1-one Hydrochloride
63. 1-propanone, 3-(((1r,2s)-2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hydrochloride (1:1), Rel-
64. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenethyl)amino)-1-(3-methoxyphenyl)-, Hydrochloride, (r*,s*)-(+-)-
65. 3-(((.alpha.s,.beta.r)-.beta.-hydroxy-.alpha.-methylphenethyl)amino)-3'-methoxypropiophenone Hydrochloride
66. 3-((1r,2s)-1-hydroxy-1-phenylpropan-2-ylamino)-1-(3-methoxyphenyl)propan-1-one Hydrochloride
67. 3-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)-1-propanone Hydrochloride
68. Propiophenone, 3-((.beta.-hydroxy-.alpha.-methylphenethyl)amino)-3'-methoxy-, Hydrochloride, (-)-
| Molecular Weight | 349.8 g/mol |
|---|---|
| Molecular Formula | C19H24ClNO3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 349.1444713 g/mol |
| Monoisotopic Mass | 349.1444713 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 355 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)